The Science Layer

THC — Receptor Mechanics & Pharmacokinetics

How THC Binds

Delta-9-tetrahydrocannabinol is a partial agonist at the CB1 receptor, which is concentrated in the central nervous system — brain, spinal cord, and peripheral nerve endings. When THC binds to CB1, it inhibits the release of neurotransmitters like GABA and glutamate, disrupting the normal signaling patterns. This is the mechanism behind the psychoactive effect: altered dopamine release, changes in short-term memory encoding, shifts in sensory perception, and appetite stimulation.

Why Potency Numbers Mislead

The THC percentage on a legal cannabis package represents total THC content by dry weight. This measurement captures THCa (the acidic precursor) converted to THC through decarboxylation, plus any free THC already present. But this number doesn’t account for terpene interactions that modulate receptor binding, the quality of the cure (which affects bioavailability), individual endocannabinoid tone (your baseline receptor density and sensitivity), or the method of consumption. Two products at 25% THC can produce radically different experiences based on these variables.

Pharmacokinetics by Route

Inhalation: onset in 2–10 minutes, peak at 15–30 minutes, duration 2–4 hours. Bioavailability approximately 10–35%. Oral ingestion: onset 30–90 minutes, peak at 2–4 hours, duration 6–10 hours. THC is converted to 11-hydroxy-THC in the liver — a more potent metabolite that crosses the blood-brain barrier more readily. Bioavailability 4–20% but the active metabolite compensates. Sublingual: onset 15–45 minutes, partial bypass of first-pass metabolism.

References: Grotenhermen (2003), Clinical Pharmacokinetics of Cannabinoids; Huestis (2007), Human Cannabinoid Pharmacokinetics; MacCallum & Russo (2018), Practical considerations in medical cannabis administration.

← Back to Basics

CBD — Mechanisms Beyond the Hype

Receptor Interactions

Unlike THC, CBD has low affinity for CB1 and CB2 receptors. Its pharmacological profile is broader and more complex: it acts as a negative allosteric modulator at CB1 (meaning it changes the shape of the receptor, reducing THC’s ability to bind), an agonist at 5-HT1A serotonin receptors (which may explain anxiolytic effects), an inhibitor of fatty acid amide hydrolase (FAAH, the enzyme that breaks down anandamide), and a modulator of TRPV1 vanilloid receptors (involved in pain perception).

What the Research Actually Supports

The strongest clinical evidence for CBD is in treatment-resistant epilepsy (Epidiolex, FDA-approved). Growing evidence supports applications in anxiety disorders, chronic inflammatory pain, and certain sleep disturbances. The evidence for CBD in cancer treatment, autism, and cardiovascular disease is preliminary at best. The wellness industry has outrun the science by approximately a decade. This doesn’t mean CBD is ineffective — it means consumers deserve honest information about what is established versus what is hoped for.

Bioavailability Challenges

Oral CBD bioavailability is approximately 6–19%. Most of the CBD in that gummy is destroyed by first-pass metabolism. Sublingual administration improves absorption. Inhaled CBD has higher bioavailability (up to 31%) but shorter duration. The delivery method matters more than the dosage number on the package.

References: Devinsky et al. (2017), NEJM trial of Epidiolex; Blessing et al. (2015), CBD as a potential treatment for anxiety disorders; Millar et al. (2018), A systematic review of CBD dosing in clinical populations.

← Back to Basics

Terpenes — The Entourage Effect in Detail

Major Cannabis Terpenes

Myrcene — the most abundant terpene in most cannabis cultivars. Also found in mangoes, hops, and lemongrass. Research suggests sedative and muscle-relaxant properties. Myrcene may enhance THC’s ability to cross the blood-brain barrier, which is one proposed mechanism for the “couch lock” effect in myrcene-dominant strains.

Limonene — citrus aroma. Found in lemon rind, orange peel, juniper. Associated with elevated mood and stress relief. Research indicates anxiolytic properties and potential gastric acid neutralization. Limonene-dominant strains tend toward energetic, uplifting experiences.

Pinene — the most common terpene in nature. Pine needles, rosemary, basil. May counteract some of THC’s short-term memory impairment by inhibiting acetylcholinesterase. Anti-inflammatory properties demonstrated in multiple studies.

Linalool — lavender. Anxiolytic and sedative properties well-documented in aromatherapy research. In cannabis, linalool may contribute to calming, anti-anxiety effects. Also demonstrates local anesthetic properties.

The Entourage Effect

First proposed by Mechoulam and Ben-Shabat (1998), the entourage effect describes how cannabinoids and terpenes work synergistically. The whole-plant experience is different from isolated THC because terpenes modulate receptor binding, influence absorption, and activate their own pharmacological pathways. This is why strain matters beyond the numbers, and why full-spectrum products produce different effects than distillates.

References: Russo (2011), Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects; Mechoulam & Ben-Shabat (1999), From ‘gan-zi-gun-nu’ to anandamide and 2-arachidonoylglycerol.

← Back to Basics

The Endocannabinoid System — Complete Architecture

Discovery

The endocannabinoid system was discovered through cannabis research. Scientists knew THC produced effects, and they worked backward to find out why. In 1988, Allyn Howlett and William Devane identified the first cannabinoid receptor (CB1). In 1992, Raphael Mechoulam’s team isolated anandamide — the first known endocannabinoid, named from the Sanskrit word “ananda” (bliss). The ECS was hiding in plain sight inside the human body, waiting for someone to look.

Components

Receptors: CB1 (concentrated in the central nervous system, brain, lungs, liver, kidneys) and CB2 (predominantly in the immune system, spleen, bones, skin). Additional cannabinoid-sensitive receptors include GPR55, TRPV1, and PPARs.

Endocannabinoids: Anandamide (AEA) and 2-arachidonoylglycerol (2-AG). These are produced on demand, not stored. They’re synthesized from cell membrane fatty acids when the body needs to restore balance.

Enzymes: FAAH breaks down anandamide. MAGL breaks down 2-AG. The speed of enzymatic degradation determines how long endocannabinoid signaling lasts.

What It Regulates

The ECS is fundamentally a homeostatic regulator. It helps maintain balance in: sleep/wake cycles, appetite and metabolism, pain perception, immune response, mood and emotional processing, memory consolidation, reproductive function, and bone density. When the system is functioning properly, you don’t notice it. When it’s disrupted, the downstream effects touch nearly every biological system.

References: Lu & Mackie (2016), An introduction to the endogenous cannabinoid system; Pacher et al. (2006), The endocannabinoid system as an emerging target of pharmacotherapy.

← Back to Basics

Consumption Methods — Pharmacokinetic Profiles

Inhalation (Smoking & Vaping)

Combustion delivers cannabinoids through the alveoli of the lungs directly into the bloodstream. Onset: 2–10 minutes. Peak effects: 15–30 minutes. Duration: 2–4 hours. This is the fastest route, but combustion produces carcinogenic byproducts (benzene, toluene, naphthalene). Vaporization heats cannabis below the combustion point (typically 180–220°C), releasing cannabinoids and terpenes without most combustion toxins. Bioavailability is comparable or slightly higher with vaporization.

Oral Ingestion (Edibles)

The most misunderstood delivery method. THC passes through the digestive tract and enters the liver, where cytochrome P450 enzymes convert delta-9-THC to 11-hydroxy-THC. This metabolite is 1.5–7x more potent at the CB1 receptor and crosses the blood-brain barrier more efficiently. This is why edibles produce a qualitatively different experience, not just a longer one. Onset: 30–120 minutes (highly variable based on stomach contents, metabolism, body composition). Duration: 6–10 hours. Bioavailability: 4–20%.

Sublingual & Oral Mucosal

Oils and tinctures absorbed through the tissues under the tongue partially bypass first-pass liver metabolism. This provides faster onset than edibles (15–45 minutes) with more predictable dosing. The cannabinoid profile remains closer to the original product because less conversion to 11-hydroxy-THC occurs.

Topicals

Cannabis-infused creams, balms, and transdermal patches. Standard topicals do not reach the bloodstream — they interact with CB1 and CB2 receptors in the skin and underlying tissue. No psychoactive effects. Useful for localized pain and inflammation. Transdermal patches are different — they are designed to penetrate into the bloodstream and can produce systemic effects.

References: Grotenhermen (2003), Clinical Pharmacokinetics of Cannabinoids; Barrus et al. (2016), Tasty THC: Promises and challenges of cannabis edibles.

← Back to Basics

Concentrates — Extraction Science

Solvent-Based Extraction

BHO (Butane Hash Oil): Butane strips cannabinoids and terpenes from plant material. The solvent is then purged under vacuum. Produces shatter (stable, glass-like), wax (opaque, crumbly), budder (whipped consistency), and sauce (high-terpene liquid with THCa crystals). Quality depends entirely on purging completeness — residual solvent testing is mandatory in legal markets for good reason.

CO2 Extraction: Supercritical carbon dioxide acts as a tunable solvent. Higher pressure extracts more cannabinoids; lower pressure preserves more terpenes. CO2 extraction is generally considered cleaner than BHO, but the equipment cost is significantly higher. Commonly used for vape cartridges and oils.

Solventless Extraction

Rosin: Heat and pressure applied to flower or hash. No solvents. The result is a full-spectrum extract that preserves the original terpene profile. Quality rosin from quality input material is considered by many to be the pinnacle of cannabis extraction.

Ice Water Hash (Bubble Hash): Ice water agitation separates trichome heads from plant material. Filtered through progressively finer mesh bags. The result is a concentrate that is mechanically separated, not chemically extracted. Full-melt hash (the highest grade) vaporizes cleanly with no residue.

Live Resin vs. Distillate

Live resin is made from fresh-frozen flower — harvested and immediately frozen to preserve the terpene profile at its peak. The result is a concentrate that tastes and smells like the living plant. Distillate, by contrast, is pure isolated THC — all terpenes and other cannabinoids are removed. It’s a blank slate. Some producers add terpenes back (botanical or cannabis-derived). These are fundamentally different products with fundamentally different purposes.

References: Raber et al. (2015), Understanding dabs: contamination concerns of cannabis concentrates; Romano & Hazekamp (2013), Cannabis Oil: chemical evaluation of an upcoming cannabis-based medicine.

← Back to Basics